$ESTA
ESTABLISHMENT LABS HOLDINGS INC. Stock $esta

$esta Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-Q Financial Statement

#000168875721000078 Filed on November 09, 2021

Income Statement

Concept	2021 Q4	2021 Q3	2021 Q2
Revenue	$35.31M	$29.04M	$31.99M
YoY Change	30.98%	27.6%	205.46%
Cost Of Revenue	$11.09M	$9.419M	$10.53M
YoY Change	-10.01%	23.74%	224.88%
Gross Profit	$24.23M	$19.62M	$21.47M
YoY Change	65.48%	29.54%	196.77%
Gross Profit Margin	68.6%	67.56%	67.1%
Selling, General & Admin	$27.56M	$24.78M	$21.75M
YoY Change	51.42%	65.11%	50.66%
% of Gross Profit	113.75%	126.3%	101.33%
Research & Development	$6.034M	$3.884M	$4.349M
YoY Change	34.99%	42.32%	81.28%
% of Gross Profit	24.91%	19.8%	20.26%
Depreciation & Amortization	$926.0K	$30.00K	$32.00K
YoY Change	-23.47%	50.0%	52.38%
% of Gross Profit	3.82%	0.15%	0.15%
Operating Expenses	$33.59M	$28.66M	$26.10M
YoY Change	48.24%	61.61%	55.03%
Operating Profit	-$9.366M	-$9.044M	-$4.634M
YoY Change	16.78%	249.05%	-51.74%
Interest Expense	-$3.727M	$2.293M	$2.248M
YoY Change	265.39%	-20.55%	5.54%
% of Operating Profit
Other Income/Expense, Net	-$310.0K	-$3.339M	$1.705M
YoY Change	-110.73%	-733.59%	1571.57%
Pretax Income	-$13.40M	-$14.61M	-$4.914M
YoY Change	117.93%	259.55%	-52.19%
Income Tax	$788.0K	$66.00K	$408.0K
% Of Pretax Income
Net Earnings	-$14.19M	-$14.68M	-$5.322M
YoY Change	151.61%	245.77%	-49.18%
Net Earnings / Revenue	-40.19%	-50.55%	-16.63%
Basic Earnings Per Share		-$0.61	-$0.22
Diluted Earnings Per Share	-$585.6K	-$0.61	-$0.22
COMMON SHARES
Basic Shares Outstanding	24.00M shares	24.09M shares	23.95M shares
Diluted Shares Outstanding		24.09M shares	23.95M shares

Balance Sheet

Concept	2021 Q4	2021 Q3	2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$53.42M	$64.62M	$76.81M
YoY Change	-36.79%	-20.61%	-11.1%
Cash & Equivalents	$53.42M	$64.62M	$76.81M
Short-Term Investments
Other Short-Term Assets	$2.641M	$8.726M	$4.336M
YoY Change	26.42%	61.59%	14.11%
Inventory	$28.41M	$26.65M	$23.95M
Prepaid Expenses	$2.315M
Receivables	$24.44M	$24.70M	$23.09M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$113.3M	$124.7M	$128.2M
YoY Change	-14.38%	-6.95%	-6.04%
LONG-TERM ASSETS
Property, Plant & Equipment	$18.66M	$16.78M	$16.59M
YoY Change	15.16%	3.19%	3.14%
Goodwill	$465.0K	$465.0K	$465.0K
YoY Change	0.0%	0.0%	0.0%
Intangibles	$4.371M	$3.654M	$3.859M
YoY Change	5.38%	3.31%	10.89%
Long-Term Investments
YoY Change
Other Assets	$558.0K	$447.0K	$617.0K
YoY Change	-15.96%	11.47%	71.39%
Total Long-Term Assets	$26.26M	$23.65M	$23.94M
YoY Change	9.0%	14.46%	17.41%
TOTAL ASSETS
Total Short-Term Assets	$113.3M	$124.7M	$128.2M
Total Long-Term Assets	$26.26M	$23.65M	$23.94M
Total Assets	$139.5M	$148.4M	$152.1M
YoY Change	-10.78%	-4.09%	-2.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$14.48M	$10.26M	$10.02M
YoY Change	48.89%	47.5%	20.82%
Accrued Expenses	$16.24M	$19.18M	$16.18M
YoY Change	11.73%	58.6%	53.85%
Deferred Revenue	$769.0K	$603.0K	$654.0K
YoY Change	-36.66%	-11.71%	-10.16%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$13.00K		$43.00K
YoY Change	-93.5%		-57.0%
Total Short-Term Liabilities	$31.89M	$30.45M	$27.27M
YoY Change	23.12%	51.18%	32.69%
LONG-TERM LIABILITIES
Long-Term Debt	$51.91M	$51.34M	$50.81M
YoY Change	4.16%	3.99%	3.82%
Other Long-Term Liabilities	$2.392M	$2.145M	$2.219M
YoY Change	2.57%	-16.92%	9.53%
Total Long-Term Liabilities	$54.30M	$53.49M	$53.03M
YoY Change	4.09%	2.95%	4.05%
TOTAL LIABILITIES
Total Short-Term Liabilities	$31.89M	$30.45M	$27.27M
Total Long-Term Liabilities	$54.30M	$53.49M	$53.03M
Total Liabilities	$88.79M	$86.80M	$83.29M
YoY Change	9.04%	16.15%	11.02%
SHAREHOLDERS EQUITY
Retained Earnings	-$206.4M	-$192.2M	-$177.5M
YoY Change	24.9%	20.42%	14.26%
Common Stock	$219.7M	$219.2M	$216.0M
YoY Change	2.94%	3.04%	1.92%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.854M	$2.854M	$2.854M
YoY Change	0.0%	0.0%	0.0%
Treasury Stock Shares	408.1K shares	408.1K shares	408.1K shares
Shareholders Equity	$50.74M	$61.56M	$68.83M
YoY Change
Total Liabilities & Shareholders Equity	$139.5M	$148.4M	$152.1M
YoY Change	-10.78%	-4.09%	-2.99%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2021 Q2
OPERATING ACTIVITIES
Net Income	-$14.19M	-$14.68M	-$5.322M
YoY Change	151.61%	245.77%	-49.18%
Depreciation, Depletion And Amortization	$926.0K	$30.00K	$32.00K
YoY Change	-23.47%	50.0%	52.38%
Cash From Operating Activities	-$7.709M	-$12.46M	-$818.0K
YoY Change	-324.75%	309.7%	-86.59%
INVESTING ACTIVITIES
Capital Expenditures	-$3.615M	-$1.083M	-$931.0K
YoY Change	219.91%	9.39%	10.83%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	-$4.000K
YoY Change		-100.0%	-99.2%
Cash From Investing Activities	-$3.615M	-$1.083M	-$935.0K
YoY Change	222.77%	-49.86%	-29.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	207.0K	1.637M	418.0K
YoY Change	-61.67%	1718.89%	280.0%
NET CHANGE
Cash From Operating Activities	-7.709M	-12.46M	-818.0K
Cash From Investing Activities	-3.615M	-1.083M	-935.0K
Cash From Financing Activities	207.0K	1.637M	418.0K
Net Change In Cash	-11.12M	-11.90M	-1.335M
YoY Change	-490.07%	132.9%	-81.76%
FREE CASH FLOW
Cash From Operating Activities	-$7.709M	-$12.46M	-$818.0K
Capital Expenditures	-$3.615M	-$1.083M	-$931.0K
Free Cash Flow	-$4.094M	-$11.37M	$113.0K
YoY Change	-189.78%	454.73%	-102.15%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Country Region CountryRegion	506
	dei	City Area Code CityAreaCode	24
	dei	Local Phone Number LocalPhoneNumber	34 2400
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Central Index Key EntityCentralIndexKey	0001688757
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2021Q3	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2021-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38593
	dei	Entity Registrant Name EntityRegistrantName	Establishment Labs Holdings Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	D8
	dei	Entity Address Address Line1 EntityAddressAddressLine1	Building B15 and 25
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Coyol Free Zone
	dei	Entity Address City Or Town EntityAddressCityOrTown	Alajuela
	dei	Entity Address Country EntityAddressCountry	CR
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Security12b Title Security12bTitle	Common Shares, No Par Value
	dei	Trading Symbol TradingSymbol	ESTA
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	24003667	shares
CY2021Q3	us-gaap	Cash Cash	64623000	USD
CY2020Q4	us-gaap	Cash Cash	84523000	USD
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1542000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1143000	USD
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	24704000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	19127000	USD
CY2021Q3	us-gaap	Inventory Net InventoryNet	26652000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	23210000	USD
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8726000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5439000	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	124705000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	132299000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16781000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16202000	USD
CY2021Q3	us-gaap	Goodwill Goodwill	465000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	465000	USD
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3654000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4148000	USD
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2307000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2610000	USD
CY2021Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	447000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	664000	USD
CY2021Q3	us-gaap	Assets Assets	148359000	USD
CY2020Q4	us-gaap	Assets Assets	156388000	USD
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	10257000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	9722000	USD
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19178000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	14532000	USD
CY2021Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1015000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1646000	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	30450000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	25900000	USD
CY2021Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	51343000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	49832000	USD
CY2021Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	894000	USD
CY2020Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1440000	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1967000	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1967000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1923000	USD
CY2021Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2145000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2332000	USD
CY2021Q3	us-gaap	Liabilities Liabilities	86799000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	81427000	USD
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24394766	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23925789	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23986696	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23517719	shares
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	219216000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	213471000	USD
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	33856000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	26717000	USD
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	408070	shares
CY2021Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	408070	shares
CY2021Q3	us-gaap	Treasury Stock Value TreasuryStockValue	2854000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2854000	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-192194000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-165246000	USD
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3536000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2873000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	61560000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	74961000	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	148359000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	156388000	USD
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29039000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22758000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	91369000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	57713000	USD
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	9419000	USD
CY2020Q3	us-gaap	Cost Of Revenue CostOfRevenue	7612000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	30191000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	19855000	USD
CY2021Q3	us-gaap	Gross Profit GrossProfit	19620000	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	15146000	USD
	us-gaap	Gross Profit GrossProfit	61178000	USD
	us-gaap	Gross Profit GrossProfit	37858000	USD
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	24780000	USD
CY2020Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15008000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	64671000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	48430000	USD
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3884000	USD
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2729000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12281000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9327000	USD
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	28664000	USD
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	17737000	USD
	us-gaap	Operating Expenses OperatingExpenses	76952000	USD
	us-gaap	Operating Expenses OperatingExpenses	57757000	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-9044000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2591000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-15774000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-19899000	USD
CY2021Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	7000	USD
CY2020Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	2000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	15000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	12000	USD
CY2021Q3	us-gaap	Interest Expense InterestExpense	2293000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	2886000	USD
	us-gaap	Interest Expense InterestExpense	6736000	USD
	us-gaap	Interest Expense InterestExpense	7162000	USD
CY2021Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	57000	USD
CY2020Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	879000	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	546000	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	442000	USD
CY2021Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2020Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-5000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-304000	USD
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3339000	USD
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	527000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4360000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5561000	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14612000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4064000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-26309000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-31864000	USD
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	66000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	181000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	639000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	606000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-14678000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-4245000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-26948000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-32470000	USD
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.61
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.61
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.13
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.13
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.40
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.40
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24091546	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24091546	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23611925	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23611925	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23885412	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23885412	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23184322	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23184322	shares
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-14678000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-4245000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-26948000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-32470000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1280000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	278000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	663000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	3312000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1280000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	278000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	663000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	3312000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-26285000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-29158000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	74961000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1882000	USD
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13398000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3967000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1756000	USD
CY2021Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	41000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	941000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-6948000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	72551000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	635000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2557000	USD
CY2021Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	34000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1558000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-5322000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	68829000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3078000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3064000	USD
CY2021Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	13000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1280000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-14678000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	61560000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	39614000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	63855000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	181000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1629000	USD
CY2020Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	34000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2821000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-17753000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	90313000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	193000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1557000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	758000	USD
CY2020Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	13000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	213000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-10472000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	81791000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	618000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	192000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1348000	USD
CY2020Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	18000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	278000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-4245000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	79964000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-26948000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-32470000	USD
	esta	Depreciation And Amortization Excluding Debt Discount Premium DepreciationAndAmortizationExcludingDebtDiscountPremium	2792000	USD
	esta	Depreciation And Amortization Excluding Debt Discount Premium DepreciationAndAmortizationExcludingDebtDiscountPremium	2502000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	477000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	93000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	1512000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	7377000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	4534000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-133000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-152000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-3317000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-5043000	USD
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	305000	USD
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	256000	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	546000	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	442000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-304000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1512000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1232000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6795000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3291000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5289000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1722000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3320000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1043000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-204000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	30000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	660000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3267000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	6828000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1725000	USD
	esta	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-309000	USD
	esta	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-218000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-314000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	461000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19823000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15944000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2667000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2136000	USD
	esta	Payments To Acquire Assets Including Receivables Held PaymentsToAcquireAssetsIncludingReceivablesHeld	434000	USD
	esta	Payments To Acquire Assets Including Receivables Held PaymentsToAcquireAssetsIncludingReceivablesHeld	1652000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	447000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	647000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3548000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4435000	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	163000	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	224000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	63855000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4096000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	566000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	88000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	65000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3845000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	64132000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-374000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-19900000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	43776000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	84523000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37655000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	64623000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	81431000	USD
	us-gaap	Interest Paid Net InterestPaidNet	5182000	USD
	us-gaap	Interest Paid Net InterestPaidNet	5213000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	429000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	34000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	252000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	618000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Inventory Acquired1 NoncashOrPartNoncashAcquisitionInventoryAcquired1	0	USD
	us-gaap	Noncash Or Part Noncash Acquisition Inventory Acquired1 NoncashOrPartNoncashAcquisitionInventoryAcquired1	1009000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	0	USD
	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	138000	USD
	esta	Noncash Consideration Payable Related To Asset Acquisition NoncashConsiderationPayableRelatedToAssetAcquisition	412000	USD
	esta	Noncash Consideration Payable Related To Asset Acquisition NoncashConsiderationPayableRelatedToAssetAcquisition	818000	USD
	esta	Noncash Proceeds From Stock Options Exercised NoncashProceedsFromStockOptionsExercised	1640000	USD
	esta	Noncash Proceeds From Stock Options Exercised NoncashProceedsFromStockOptionsExercised	0	USD
CY2021Q3	esta	Number Of Manufacturing Facilities NumberOfManufacturingFacilities	2	facility
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6.25pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Significant accounting </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">estimates and management judgments reflected in the condensed </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> financial statements include items such as accounts receivable valuation and allowances, inventory valuation and allowances, valuation of acquired intangible assets, valuation of derivatives, estimation of assets’ useful lives and valuation of deferred income tax assets, including tax valuation allowances. Estimates are based</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on historical experience, where applicable, and other assumptions believed to be reasonable by management. Actual results may differ from those estimates under different assumptions or conditions.</span></div>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties</span></div><div style="margin-bottom:6pt;margin-top:6.25pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash and accounts receivable. The majority of the Company’s cash is held at two financial institutions in the United States. Balances in the Company’s cash accounts exceed the Federal Deposit Insurance Corporation, or FDIC, limit of $250,000. The Company has not experienced any losses to its deposits of cash.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company’s revenue has been derived from sales of its products in international markets, principally Europe, the Middle East, Latin America, and Asia. In the international markets in which the Company participates, the Company uses a combination of distributors and makes direct sales to customers. The Company performs ongoing credit evaluations of its distributors and customers, does not require collateral, and maintains allowances for potential credit losses on customer accounts when deemed necessary.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of the Company’s revenues were derived from the sale of Motiva Implants. During the nine months ended September 30, 2021 and 2020, no customer accounted for more than 10% of the Company’s revenue. One customer accounted for 11.8% and another customer accounted for 10.1% of the Company’s trade accounts receivable balance as of September 30, 2021. No customer accounted for more than 10% of the Company’s trade accounts receivable balance as of </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2020</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company relies on NuSil Technology, LLC, or NuSil, as the sole supplier of medical-grade silicone used in Motiva Implants. During the nine months ended September 30, 2021 and 2020, the Company had purchases of $17.4 million, or 59.9% of total purchases, and $12.1 million, or 67.1% of total purchases, respectively, from NuSil. As of September 30, 2021 and </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2020</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company had an outstanding balance owed to this vendor of $2.0 million and $1.3 million, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s future results of operations involve a number of risks and uncertainties. Factors that could affect the Company’s future operating results and cause actual results to vary materially from expectations include, but are not limited to, uncertainty of regulatory approval of the Company’s current and potential future products, uncertainty of market acceptance of the Company’s products, competition from substitute products and larger companies, securing and protecting proprietary technology, access to capital, strategic relationships and dependence on key individuals and sole source suppliers. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Products developed by the Company require clearances from the FDA or other international regulatory agencies prior to commercial sales. There can be no assurance that the products will receive the necessary clearances. If </span></div>the Company is denied clearance, clearance is delayed, or the Company is unable to maintain its existing clearances, these developments could have a material adverse impact on the Company.
CY2020Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	USD
CY2021Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	USD
CY2021Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1600000	USD
CY2020Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1600000	USD
	esta	Revenue From Contract With Customer Product Return Period RevenueFromContractWithCustomerProductReturnPeriod	P15D
CY2021Q3	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	5000	USD
CY2020Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	54000	USD
CY2020	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29039000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22758000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	91369000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	57713000	USD
	esta	Revenue From Contract With Customer Product Shelf Life RevenueFromContractWithCustomerProductShelfLife	P5Y
	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P50Y
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reportingunit
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
	us-gaap	Derivatives Embedded Derivatives DerivativesEmbeddedDerivatives	<div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt and Embedded Derivatives</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the accounting standards for derivatives and hedging and for distinguishing liabilities from equity when accounting for hybrid contracts. The Company accounts for convertible debt instruments when the Company has determined that the embedded conversion options should not be bifurcated from their host instruments in accordance with ASC 470-20 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt with Conversion and Other Options</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (see Note 6).</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses option pricing valuation models to determine the fair value of embedded derivatives and records any change in fair value as a component of other income or expense in the condensed consolidated statements of operations (see Note 5).</span></div>
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-4000000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-5400000	USD
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to prior year amounts to conform to the current year presentation due to the adoption of Accounting Standards Update, or ASU, No. 2016-02, </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842)</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> effective January 1, 2020, using the modified retrospective approach. These reclassifications had no material impact on the results of operations or the cash flows of the Company for the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> months ended </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September 30, 2020</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div>
CY2021Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	6672000	USD
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	5450000	USD
CY2021Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1462000	USD
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1121000	USD
CY2021Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	18518000	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	16639000	USD
CY2021Q3	us-gaap	Inventory Net InventoryNet	26652000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	23210000	USD
CY2020Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	2000000	USD
CY2021Q3	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	3300000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	28090000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	25835000	USD
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11309000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9633000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16781000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16202000	USD
CY2020Q3	esta	Depreciation And Amortization Property Plant And Equipment DepreciationAndAmortizationPropertyPlantAndEquipment	600000	USD
CY2021Q3	esta	Depreciation And Amortization Property Plant And Equipment DepreciationAndAmortizationPropertyPlantAndEquipment	600000	USD
	esta	Depreciation And Amortization Property Plant And Equipment DepreciationAndAmortizationPropertyPlantAndEquipment	1800000	USD
	esta	Depreciation And Amortization Property Plant And Equipment DepreciationAndAmortizationPropertyPlantAndEquipment	1800000	USD
CY2021Q3	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	1400000	USD
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	1400000	USD
CY2021Q3	us-gaap	Depreciation Depreciation	30000	USD
CY2020Q3	us-gaap	Depreciation Depreciation	20000	USD
	us-gaap	Depreciation Depreciation	97000	USD
	us-gaap	Depreciation Depreciation	62000	USD
CY2021Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2489000	USD
CY2020Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2406000	USD
CY2021Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	8435000	USD
CY2020Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	2781000	USD
CY2021Q3	esta	Accrued Stock Option Grant Bonus Current AccruedStockOptionGrantBonusCurrent	5216000	USD
CY2020Q4	esta	Accrued Stock Option Grant Bonus Current AccruedStockOptionGrantBonusCurrent	5992000	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	435000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	788000	USD
CY2021Q3	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	747000	USD
CY2020Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	628000	USD
CY2021Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	771000	USD
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	439000	USD
CY2021Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	223000	USD
CY2020Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	237000	USD
CY2021Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	862000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1261000	USD
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19178000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	14532000	USD
CY2021Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	603000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1214000	USD
CY2021Q3	esta	Cash Payable For Asset Acquisition Current CashPayableForAssetAcquisitionCurrent	412000	USD
CY2020Q4	esta	Cash Payable For Asset Acquisition Current CashPayableForAssetAcquisitionCurrent	432000	USD
CY2021Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1015000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1646000	USD
CY2021Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2138000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1860000	USD
CY2021Q3	esta	Cash Payable For Asset Acquisition Noncurrent CashPayableForAssetAcquisitionNoncurrent	0	USD
CY2020Q4	esta	Cash Payable For Asset Acquisition Noncurrent CashPayableForAssetAcquisitionNoncurrent	425000	USD
CY2021Q3	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	7000	USD
CY2020Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	47000	USD
CY2021Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2145000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2332000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	465000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021Q3	us-gaap	Goodwill Goodwill	465000	USD
CY2021Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	291000	USD
CY2021Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	291000	USD
CY2021Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	7416000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3762000	USD
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3654000	USD
CY2020Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	291000	USD
CY2020Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	291000	USD
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	6967000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2819000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4148000	USD
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	300000	USD
CY2020Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	900000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	700000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	251000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	906000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	648000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	622000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	424000	USD
CY2021Q3	esta	Finite Lived Intangible Assets Amortization Expense After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour	512000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3363000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	491000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	457000	USD
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	7000	USD
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	7000	USD
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	313000	USD
CY2021Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	12000	USD
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	19000	USD
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	97000	USD
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	62000	USD
	us-gaap	Lease Cost LeaseCost	104000	USD
	us-gaap	Lease Cost LeaseCost	81000	USD
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2307000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2610000	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	435000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	788000	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1967000	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1967000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1923000	USD
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	2402000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2711000	USD
CY2021Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	182000	USD
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	160000	USD
CY2021Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	13000	USD
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	28000	USD
CY2021Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	25000	USD
CY2020Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	188000	USD
CY2021Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y6M
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y2M12D
CY2021Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y8M12D
CY2020Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y
CY2021Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.105
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.105
CY2021Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.086
CY2020Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.091
	us-gaap	Operating Lease Payments OperatingLeasePayments	481000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	429000	USD
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	7000	USD
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	7000	USD
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	19000	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	163000	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	224000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	355000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	170000	USD
CY2021Q3	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	12000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	594000	USD
CY2021Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	14000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	565000	USD
CY2021Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	0	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	532000	USD
CY2021Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	0	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	449000	USD
CY2021Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	0	USD
CY2021Q3	esta	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	878000	USD
CY2021Q3	esta	Finance Lease Liability To Be Paid After Year Four FinanceLeaseLiabilityToBePaidAfterYearFour	0	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3188000	USD
CY2021Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	26000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	786000	USD
CY2021Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	1000	USD
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	2402000	USD
CY2021Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	25000	USD
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24394766	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23925789	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23986696	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23517719	shares
CY2021Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	4646503	shares
CY2020Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	4182196	shares
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3064000	USD
CY2020Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1347000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7377000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4534000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2012960	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	16.71
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y9M
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	42126000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	40.66
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	666293	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	72.56
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	462128	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	12.41
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	136964	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	29.86
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2080161	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	34.69
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y10M6D
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	78278000	USD
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	822216	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	13.90
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	47400000	USD
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	462128	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	12.41
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	25400000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1000000	USD
CY2021Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	26300000	USD
	esta	Employee And Non Employee Service Share Based Compensation Nonvested Awards Compensation Cost Not Yet Recognized Period For Recognition EmployeeAndNonEmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedPeriodForRecognition	P2Y7M6D
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-14678000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-4245000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-26948000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-32470000	USD
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24091546	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24091546	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23611925	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23611925	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23885412	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23885412	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23184322	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23184322	shares
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.61
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.61
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.13
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.13
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.40
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.40
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1898720	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1843717	shares

Files In Submission

Name	View Source	Status
0001688757-21-000078-index-headers.html	Edgar Link	pending
0001688757-21-000078-index.html	Edgar Link	pending
0001688757-21-000078.txt	Edgar Link	pending
0001688757-21-000078-xbrl.zip	Edgar Link	pending
esta-20210930.htm	Edgar Link	pending
esta-20210930.xsd	Edgar Link	pending
esta-20210930_cal.xml	Edgar Link	unprocessable
esta-20210930_def.xml	Edgar Link	unprocessable
esta-20210930_htm.xml	Edgar Link	completed
esta-20210930_lab.xml	Edgar Link	unprocessable
esta-20210930_pre.xml	Edgar Link	unprocessable
exhibit311q32021.htm	Edgar Link	pending
exhibit312q32021.htm	Edgar Link	pending
exhibit321q32021.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ESTA
ESTABLISHMENT LABS HOLDINGS INC. Stock $esta

2021 Q4 Form 10-Q Financial Statement

#000168875721000078 Filed on November 09, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ESTA ESTABLISHMENT LABS HOLDINGS INC. Stock $esta

2021 Q4 Form 10-Q Financial Statement

#000168875721000078 Filed on November 09, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ESTA
ESTABLISHMENT LABS HOLDINGS INC. Stock $esta